References
Bartsch R, Rottenfusser A, Wenzel C et al (2007) Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer. J Neurooncol Jun 8 [Epub ahead of print]
van Vulpen M, Kal HB, Taphoorn MJ, El-Sharouni SY (2002) Changes in blood–brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). Oncol Rep 9:683–688
Liang K, Lu Y, Jin W et al (2003) Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2:1113–1120
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bulut, N., Harputluoglu, H., Dizdar, O. et al. Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer. J Neurooncol 86, 241 (2008). https://doi.org/10.1007/s11060-007-9447-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9447-7